[1] |
Redd TK, Seitzman GD. Ocular rosacea[J]. Curr Opin Ophthalmol, 2020,31(6):503⁃507. doi: 10.1097/ICU.0000000000000706.
|
[2] |
van Zuuren EJ, Arents B, van der Linden M, et al. Rosacea: new concepts in classification and treatment[J]. Am J Clin Dermatol, 2021,22(4):457⁃465. doi: 10.1007/s40257⁃021⁃00595⁃7.
|
[3] |
Gallo RL, Granstein RD, Kang S, et al. Standard classification and pathophysiology of rosacea: the 2017 update by the National Rosacea Society Expert Committee[J]. J Am Acad Dermatol, 2018,78(1):148⁃155. doi: 10.1016/j.jaad.2017.08.037.
|
[4] |
Yu K, Bunya V, Maguire M, et al. Systemic conditions associated with severity of dry eye signs and symptoms in the dry eye assessment and management study[J]. Ophthalmology, 2021,128(10):1384⁃1392. doi: 10.1016/j.ophtha.2021.03.030.
|
[5] |
何文婷, 卞薇, 李国琴, 等. 恒温氧气超声雾化联合睑板腺疏通治疗睑板腺功能障碍性干眼症的效果[J]. 临床与病理杂志, 2021,41(6):1267⁃1273. doi: 10.3978/j.issn.2095⁃6959.2021. 06.005.
|
[6] |
中国医师协会皮肤科医师分会皮肤美容亚专业委员会. 中国玫瑰痤疮诊疗专家共识(2016)[J]. 中华皮肤科杂志, 2017,50(3):156⁃161. doi: 10.3760/cma.j.issn.0412⁃4030.2017.03.002.
|
[7] |
Gallo RL, Baldwin H, Gold LS, et al. Update on facial erythema in rosacea[J]. J Drugs Dermatol, 2021,20(8):861⁃864. doi: 10.36849/JDD.6062.
|
[8] |
Barradas Lopes J, Santa C, Valente C, et al. Allergy to lipid transfer proteins (LTP) in a pediatric population[J]. Eur Ann Allergy Clin Immunol, 2021. doi: 10.23822/EurAnnACI.1764⁃1489.229.
|
[9] |
Ghanem VC, Mehra N, Wong S, et al. The prevalence of ocular signs in acne rosacea: comparing patients from ophthalmology and dermatology clinics[J]. Cornea, 2003,22(3):230⁃233. doi: 10.1097/00003226⁃200304000⁃00009.
|
[10] |
中华医学会皮肤性病学分会玫瑰痤疮研究中心, 中国医师协会皮肤科医师分会玫瑰痤疮专业委员会. 中国玫瑰痤疮诊疗指南(2021版)[J]. 中华皮肤科杂志, 2021,54(4):279⁃288. doi: 10.35541/cjd.20201078.
|
[11] |
Karaman Erdur S, Eliacik M, Kocabora MS, et al. Tear osmolarity and tear film parameters in patients with ocular rosacea[J]. Eye Contact Lens, 2016,42(6):347⁃349. doi: 10. 1097/ICL.0000000000000211.
|
[12] |
熊健霞, 陈爽, 蔡涛. 微生物在玫瑰痤疮中致病机制的研究进展[J]. 皮肤性病诊疗学杂志, 2021,28(2):144⁃147. doi: 10. 3969/j.issn.1674⁃8468.2021.02.016.
|
[13] |
Kara YA, Çalış F, Gürel İB. Ocular manifestations of patients with cutaneous rosacea with and without Demodex infection[J]. Cutis, 2021,108(1):46⁃50. doi: 10.12788/cutis.0289.
|
[14] |
Barabino S, Aragona P, di Zazzo A, et al. Updated definition and classification of dry eye disease: renewed proposals using the nominal group and Delphi techniques[J]. Eur J Ophthalmol, 2021,31(1):42⁃48. doi: 10.1177/1120672120960586.
|
[15] |
Brar S, Vanga HR, Ganesh S. Comparison of efficacy of trehalose⁃based eye drops versus topical 0.1% Hyaluronic Acid for management of clinically significant dry eye using non⁃invasive investigational modalities[J]. Int Ophthalmol, 2021,41(10):3349⁃3359. doi: 10.1007/s10792⁃021⁃01897⁃9.
|
[16] |
McMonnies CW. Dry eye disease immune responses and topical therapy[J]. Eye Vis (Lond), 2019,6:12. doi: 10.1186/s40662⁃019⁃0137⁃2.
|
[17] |
Yan S, Wu Y. Efficacy and safety of intense pulsed light therapy for dry eye caused by meibomian gland dysfunction: a randomised trial[J]. Ann Palliat Med, 2021,10(7):7857⁃7865. doi: 10.21037/apm⁃21⁃1303.
|